ID   ANR11_MOUSE             Reviewed;        2643 AA.
AC   E9Q4F7; B2RY01; Q6PB57;
DT   08-JUN-2016, integrated into UniProtKB/Swiss-Prot.
DT   05-APR-2011, sequence version 1.
DT   07-APR-2021, entry version 72.
DE   RecName: Full=Ankyrin repeat domain-containing protein 11 {ECO:0000312|MGI:MGI:1924337};
GN   Name=Ankrd11 {ECO:0000312|MGI:MGI:1924337};
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090 {ECO:0000312|Proteomes:UP000000589};
RN   [1] {ECO:0000312|Proteomes:UP000000589}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J {ECO:0000312|Proteomes:UP000000589};
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,
RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,
RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,
RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,
RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,
RA   Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of the
RT   mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [2] {ECO:0000312|EMBL:AAH59876.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J {ECO:0000312|EMBL:AAH59876.1};
RC   TISSUE=Brain {ECO:0000312|EMBL:AAH59876.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3] {ECO:0000305}
RP   FUNCTION, AND MUTAGENESIS OF GLU-2502.
RX   PubMed=17986521; DOI=10.1152/physiolgenomics.00116.2007;
RA   Barbaric I., Perry M.J., Dear T.N., Rodrigues Da Costa A., Salopek D.,
RA   Marusic A., Hough T., Wells S., Hunter A.J., Cheeseman M., Brown S.D.;
RT   "An ENU-induced mutation in the Ankrd11 gene results in an osteopenia-like
RT   phenotype in the mouse mutant Yoda.";
RL   Physiol. Genomics 32:311-321(2008).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-276; SER-1070; THR-1111;
RP   SER-1114; SER-1676; SER-1832; TYR-1835; TYR-1836; SER-1837; SER-1844 AND
RP   SER-2139, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, Kidney, Liver, Lung, Spleen, and Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [5] {ECO:0000305}
RP   FUNCTION, AND DEVELOPMENTAL STAGE.
RX   PubMed=25556659; DOI=10.1016/j.devcel.2014.11.031;
RA   Gallagher D., Voronova A., Zander M.A., Cancino G.I., Bramall A.,
RA   Krause M.P., Abad C., Tekin M., Neilsen P.M., Callen D.F., Scherer S.W.,
RA   Keller G.M., Kaplan D.R., Walz K., Miller F.D.;
RT   "Ankrd11 is a chromatin regulator involved in autism that is essential for
RT   neural development.";
RL   Dev. Cell 32:31-42(2015).
RN   [6] {ECO:0000305}
RP   SUBCELLULAR LOCATION, PROTEASOMAL DEGRADATION, AND MUTAGENESIS OF GLU-2502.
RX   PubMed=25413698; DOI=10.1007/s00439-014-1509-2;
RA   Walz K., Cohen D., Neilsen P.M., Foster J. II, Brancati F., Demir K.,
RA   Fisher R., Moffat M., Verbeek N.E., Bjoergo K., Lo Castro A., Curatolo P.,
RA   Novelli G., Abad C., Lei C., Zhang L., Diaz-Horta O., Young J.I.,
RA   Callen D.F., Tekin M.;
RT   "Characterization of ANKRD11 mutations in humans and mice related to KBG
RT   syndrome.";
RL   Hum. Genet. 134:181-190(2015).
CC   -!- FUNCTION: Chromatin regulator which modulates histone acetylation and
CC       gene expression in neural precursor cells (PubMed:25556659). May
CC       recruit histone deacetylases (HDACs) to the p160 coactivators/nuclear
CC       receptor complex to inhibit ligand-dependent transactivation (By
CC       similarity). Has a role in proliferation and development of cortical
CC       neural precursors (PubMed:25556659). May also regulate bone homeostasis
CC       (PubMed:17986521). {ECO:0000250|UniProtKB:Q6UB99,
CC       ECO:0000269|PubMed:17986521, ECO:0000269|PubMed:25556659}.
CC   -!- SUBUNIT: Interacts with the PAS region of the p160 coactivators.
CC       {ECO:0000250|UniProtKB:Q6UB99}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:25413698}.
CC       Note=Localizes to chromatin during prometaphase (By similarity).
CC       {ECO:0000250|UniProtKB:Q6UB99}.
CC   -!- DEVELOPMENTAL STAGE: Detected in the cerebral cortex from embryonic
CC       stage 11 dpc through to postnatal stage P3, where it is primarily
CC       expressed in neural precursors. {ECO:0000269|PubMed:25556659}.
CC   -!- PTM: Subject to proteasomal degradation which is probably essential to
CC       regulate its activity. {ECO:0000269|PubMed:25413698}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC132287; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC059876; AAH59876.1; -; mRNA.
DR   EMBL; BC158043; AAI58044.1; -; mRNA.
DR   CCDS; CCDS40507.2; -.
DR   RefSeq; NP_001074848.2; NM_001081379.2.
DR   SMR; E9Q4F7; -.
DR   STRING; 10090.ENSMUSP00000095938; -.
DR   iPTMnet; E9Q4F7; -.
DR   PhosphoSitePlus; E9Q4F7; -.
DR   EPD; E9Q4F7; -.
DR   jPOST; E9Q4F7; -.
DR   MaxQB; E9Q4F7; -.
DR   PaxDb; E9Q4F7; -.
DR   PRIDE; E9Q4F7; -.
DR   ProteomicsDB; 296048; -.
DR   Antibodypedia; 4516; 130 antibodies.
DR   Ensembl; ENSMUST00000098334; ENSMUSP00000095939; ENSMUSG00000035569.
DR   GeneID; 77087; -.
DR   KEGG; mmu:77087; -.
DR   UCSC; uc009ntz.2; mouse.
DR   CTD; 29123; -.
DR   MGI; MGI:1924337; Ankrd11.
DR   eggNOG; ENOG502QQG5; Eukaryota.
DR   GeneTree; ENSGT00940000155966; -.
DR   HOGENOM; CLU_229338_0_0_1; -.
DR   OMA; YMDGFGS; -.
DR   OrthoDB; 854133at2759; -.
DR   BioGRID-ORCS; 77087; 17 hits in 53 CRISPR screens.
DR   ChiTaRS; Ankrd11; mouse.
DR   PRO; PR:E9Q4F7; -.
DR   Proteomes; UP000000589; Chromosome 8.
DR   RNAct; E9Q4F7; protein.
DR   Bgee; ENSMUSG00000035569; Expressed in heart and 262 other tissues.
DR   ExpressionAtlas; E9Q4F7; baseline and differential.
DR   Genevisible; E9Q4F7; MM.
DR   GO; GO:0005829; C:cytosol; ISO:MGI.
DR   GO; GO:0005654; C:nucleoplasm; ISO:MGI.
DR   GO; GO:0005634; C:nucleus; ISO:MGI.
DR   GO; GO:0009653; P:anatomical structure morphogenesis; IBA:GO_Central.
DR   GO; GO:0060348; P:bone development; IMP:MGI.
DR   GO; GO:0060325; P:face morphogenesis; ISO:MGI.
DR   GO; GO:0060323; P:head morphogenesis; IMP:MGI.
DR   GO; GO:0001701; P:in utero embryonic development; IMP:MGI.
DR   GO; GO:0035264; P:multicellular organism growth; IMP:MGI.
DR   GO; GO:0042475; P:odontogenesis of dentin-containing tooth; ISO:MGI.
DR   GO; GO:0048705; P:skeletal system morphogenesis; IMP:MGI.
DR   GO; GO:0001894; P:tissue homeostasis; IMP:MGI.
DR   Gene3D; 1.25.40.20; -; 1.
DR   InterPro; IPR042636; ANKRD11.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR020683; Ankyrin_rpt-contain_dom.
DR   InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR   PANTHER; PTHR24145; PTHR24145; 1.
DR   Pfam; PF00023; Ank; 1.
DR   Pfam; PF12796; Ank_2; 1.
DR   SMART; SM00248; ANK; 3.
DR   SUPFAM; SSF48403; SSF48403; 1.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 3.
PE   1: Evidence at protein level;
KW   ANK repeat; Nucleus; Phosphoprotein; Reference proteome; Repeat.
FT   CHAIN           1..2643
FT                   /note="Ankyrin repeat domain-containing protein 11"
FT                   /id="PRO_0000436376"
FT   REPEAT          167..196
FT                   /note="ANK 1"
FT                   /evidence="ECO:0000255"
FT   REPEAT          200..229
FT                   /note="ANK 2"
FT                   /evidence="ECO:0000255"
FT   REPEAT          233..262
FT                   /note="ANK 3"
FT                   /evidence="ECO:0000255"
FT   REPEAT          266..292
FT                   /note="ANK 4"
FT                   /evidence="ECO:0000255"
FT   REGION          2349..2643
FT                   /note="Important for protein degradation"
FT                   /evidence="ECO:0000250|UniProtKB:Q6UB99"
FT   COMPBIAS        478..588
FT                   /note="Ser-rich"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00016"
FT   COMPBIAS        625..1639
FT                   /note="Lys-rich"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00012"
FT   COMPBIAS        1819..1899
FT                   /note="Pro-rich"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00015"
FT   COMPBIAS        2150..2262
FT                   /note="Pro-rich"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00015"
FT   MOD_RES         276
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         408
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q6UB99"
FT   MOD_RES         410
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q6UB99"
FT   MOD_RES         411
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q6UB99"
FT   MOD_RES         838
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q6UB99"
FT   MOD_RES         1070
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         1111
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         1114
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         1676
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         1777
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q6UB99"
FT   MOD_RES         1832
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         1835
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         1836
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         1837
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         1844
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         1981
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q6UB99"
FT   MOD_RES         2139
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MUTAGEN         2502
FT                   /note="E->K: In Yoda; protein degradation is impaired.
FT                   Homozygotes are embryonic lethal. Heterozygotes have
FT                   reduced body size, craniofacial abnormalities, and reduced
FT                   bone mineral density."
FT                   /evidence="ECO:0000269|PubMed:17986521,
FT                   ECO:0000269|PubMed:25413698"
FT   CONFLICT        239
FT                   /note="H -> R (in Ref. 2; AAI58044)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   2643 AA;  296186 MW;  9442C1C4500DC15A CRC64;
     MPKGGCSKTP QQEDFALSND MVEKQTGKKD KDKVSLTKTP KLDRSDGGKE VRERATKRKL
     PFTVGANGEQ KDSDTEKQGP ERKRIKKEPV ARKSGLLFGM GLSGIRAGYP LSERQQVALL
     MQMTAEESAN SPVDTTPKHP SQSTVCQKGT PNSASKTKDK VNKRNERGET RLHRAAIRGD
     ARRIKELISE GADVNVKDFA GWTALHEACN RGYYDIAKQL LAAGAEVNTK GLDDDTPLHD
     AANNGHYKVV KLLLRYGGNP QQSNRKGETP LKVANSPTMV NLLLGKGTYT SSEESSTESS
     EEEDAPSFAP SSSVDGNNTD SEFEKGLKLK AKNPEPQKTV TPVKDEYEFD EDDEQDRVPP
     VDDKHLLKKD YRKEAKANSF ISIPKMEVKS YSKNNTLAPK KAAHRILSDT SDEEDVSVSI
     GAGEKLRLSA HTMLPGSKAR ESSSSRQQKE KNKLKKKRKK ETKGKEVRFG KRSDKFCSSG
     SESESSESEE DDGDSVGSSG CLKGSPLVLK DPSLFSSLSA SSTSSHGSAV AQKHGSGHTD
     QHTKHWRTDN WKAISSPAWS EVSSLSDSSR TGLTSESDCS SEGSSVESLK PTRRKQEHRK
     RGVLQSAPSE KRSSFHPCTD GAVPKLDKEG KVVKKHKTKH KHKHKEKGQC SVSQELKLKS
     FTYEYEDSKQ KSDKAILLES DLSTENKLKV LKHDREHLKK EDKLGRMKPE DKDWLFKDEK
     VLKRIKDANK DMSRAFREDK DRASKAERER ATKDKSPKEE KLRLYKEERK KKSKDRASRL
     ERKNDMKEDK LSKEKEKAFK EDKEKLKKEK LYREDAAFDD YCNKSQFLDH EDTKFSLSDD
     QQERWFSDLS DSSFDFKGED SWDSVTDYRD IKNDSVAKLI LETVKEDSKE KKRDNKIREK
     RDFKDSFFRK RDRDCLDKNS EKRRDQTEKH KSIPSYLSEK DKKRRESAEG GRDRRDGRIR
     SEEVHREDLK ECGFESSFKD KSDCDFPKNL EPWERPHAAR EKEKKDALEK ERKEKGRADK
     YKEKSSERER SDKSTLDKCQ KDKEFEKCFK EKKDGKEKHK DIHSKDRKAS FDQLREKKEK
     VFSSIISEDF SERKDDRKGK EKSWYIADIF TDESEDEKDD CVAGSFKATE ASDTQRVDGL
     PEKEEGREHP SDRHRKSSSD RQHTEKPRDK EPKEKKKDRG ASEGGKDKKE KMEKIFEKHK
     EKKDKECAER YKDRKERASA DSAPEKKNKQ KLPEKVEKKH FAEDKVKSKH KEKPEKEHSR
     ERERKPSRGP DVEKSLLEKL EEEALHDYRE DSNDKISEVS SDSFADHGQE PSLSTLLEVS
     FSEPPAEDKA RDSACLSEKL REKERHRHSS SSSKKSHERE RAKKEKAEKK EKSEDYKDSI
     SSVRKDASQF EKDFLDAETY GVSYPTKADV EEELDKAIEL FSSEKKDRSD PEREPAKRIE
     KELKPYGSSA ISILKEKKKR EKHRERWREE KERHRDKHVD GFLRHHKDEP KPAAKDKDNP
     PNSFKEKSRE ESLKLSETKL KEKFKENTER EKGDSIKMSN GNDKLVPSRD SGKKDSRPRE
     KLLGDGDLMM TSFERMLSQK DLEIEERHKR HKERMKQMEK MRHRSGDPKL KEKKPTEDGR
     KKSLDFPSKK ALGLDKKVKE PAPTLTTGES KPHSGPGTES KDWLSGQPLK EVLPASPRTE
     QSRPTGVPTP TSVVSCPSYE EVMHTPRTPS CSADDYPDLV FDCTDSQHSM PVSTASTSAC
     SPPFFDRFSV ASSVVSENAA GQTPTRPIST NLYRSISVDI RRTPEEEFSA GDKLFRQQSV
     PAPSSFDSPV QHLLEEKAPL PPVPAEKFAC LSPGYYSPDY GIPSPKVDTL HCPPTAVVSA
     TPPPDSVFSN LPPKSSPSPR GELLSPAIEG TLPPDLGLPL DATEDQQATA AILPQEPSYL
     EPLDEGPFTT VITEEPVEWT HTAAEQGLSS SSLIASASEN PVSWPVGSEL MLKSPQRFAE
     SPKHFCPGES LHSTTPGPYS AAEPTYPVSP GSYPLPAPEP ALEEVKDGGT GAIPVAISAA
     EGAAPYAAPA RLESFFSNCK SHPDAPLDTA PEPTGVTAVA QVEALGPLES SFLDSNPSIS
     TLSQVEPVSW HEAFTSPEDD LDLGPFSLPE LPLQAKDASD VEAEAAKASP VPPAESPPGP
     TGVLGGGDVP APAAEEPPAP PPQEASPQLS TEPEPSEEPK LDVVLEATVE TEVLADDSAP
     EASISNSVPA PSPPQQQPPG GGDEEAETED PSATPCCAPD GPTTDGLAQA HNSAEASCVV
     AAAEGPPGNV QAEATDPEPK PTSEVPKAPK VEEVPQRMTR NRAQMLASQS KQGIPAAEKD
     PMPTPASRAK GRASEEEDAQ AQHPRKRRFQ RSSQQLQQQL NTSTQQTREV IQQTLAAIVD
     AIKLDAIEPY HSDRSNPYFE YLQIRKKIEE KRKILCCITP QAPQCYAEYV TYTGSYLLDG
     KPLSKLHIPV IAPPPSLAEP LKELFKQQEA VRGKLRLQHS IEREKLIVSC EQEILRVHCR
     AARTIANQAV PFSACTMLLD SEVYNMPLES QGDENKSVRD RFNARQFISW LQDVDDKYDR
     MKTCLLMRQQ HEAAALNAVQ RMEWQLKAQE LDPAGHKSLC VNEVPSFYVP MVDVNDDFVL
     LPA
//
